0001829126-22-016171.txt : 20220825
0001829126-22-016171.hdr.sgml : 20220825
20220825161937
ACCESSION NUMBER: 0001829126-22-016171
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220825
DATE AS OF CHANGE: 20220825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NATAN DAVID
CENTRAL INDEX KEY: 0001253108
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 221197624
MAIL ADDRESS:
STREET 1: 11190 BISCAYNE BLVD
CITY: MIAMI
STATE: FL
ZIP: 33181
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
ownership.xml
3
X0206
3
2022-08-15
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001253108
NATAN DAVID
C/O TITAN PHARMACEUTICALS, INC.
400 OYSTER POINT BLVD., SUITE 505
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
0
D
No securities are beneficially owned.
/s/ David Natan
2022-08-25